Last quarter (Q1 2024), Outlook Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Outlook Therapeutics's net income was $-11.18M. See Outlook Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Total Revenue	-	-	-	-	$ 0.00	$ 8.15M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 47.76M	$ 53.13M	$ 63.95M	$ 51.73M	$ 36.31M	$ 33.18M
Operating Income	$ -47.76M	$ -53.13M	$ -63.95M	$ -51.73M	$ -36.31M	$ -25.03M
Net Non Operating Interest Income Expense	$ 890.12K	$ -1.56M	$ 3.14K	$ 5.09K	$ -1.76M	$ -3.47M
Other Income Expense	$ 65.64K	$ 537.74K	$ 608.35K	$ 498.49K	$ -441.98K	$ -9.44M
Pretax Income	$ -50.50M	$ -58.98M	$ -66.05M	$ -53.16M	$ -38.51M	$ -37.93M
Tax Provision	$ 2.80K	$ 2.80K	$ 2.80K	$ 2.00K	$ -3.27M	$ -3.41M
Earnings From Equity Interest Net Of Tax	$ -29.95K	$ -11.00K	$ -48.73K	$ -46.34K	-	-
Net Income Common Stockholders	$ -51.50M	$ -58.98M	$ -66.05M	$ -53.16M	$ -48.87M	$ -36.04M
Basic EPS	$ -0.20	$ -0.24	$ -0.31	$ -0.35	$ -0.67	$ -1.98
Diluted EPS	$ -0.20	$ -0.24	$ -0.31	$ -0.35	$ -0.67	$ -1.98
Basic Average Shares	$ 1.03B	$ 250.18M	$ 212.08M	$ 152.68M	$ 72.56M	$ 18.19M
Diluted Average Shares	$ 1.03B	$ 250.18M	$ 212.08M	$ 152.68M	$ 72.56M	$ 18.19M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ -0.47	-
Reported Normalized Diluted E P S	-	-	-	-	$ -0.47	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 47.76M	$ 53.13M	$ 63.95M	$ 51.73M	$ 36.31M	$ 33.18M
Net Income From Continuing And Discontinued Operation	$ -51.50M	$ -58.98M	$ -66.05M	$ -53.16M	$ -35.24M	$ -34.52M
Normalized Income	$ -36.68M	$ -46.59M	-	-	$ -34.84M	$ -25.93M
Interest Expense	-	-	-	-	$ 1.76M	$ 3.47M
EBIT	$ -51.39M	$ -57.42M	$ -66.05M	$ -53.17M	$ -36.75M	$ -34.47M
EBITDA	$ -51.33M	$ -57.38M	$ -65.85M	$ -52.90M	$ -36.20M	$ -31.11M

Currency in USD

Outlook Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing